leisure time -WSS

leisure time

author：knowledge 2025-10-02 17:50:23 - browse：8319

An army of wooden figures under blue and pink lighting — biotech coverage from STAT — Adobe

Biotech startup ReNAgade Therapeutics is cutting staff just seven months after raising the largest Series A round in the industry this year.

ReNAgade launched in May with hopes of becoming a one-stop shop for medicines targeting RNA, the genetic blueprints that cells use to make proteins instrumental in numerous diseases. These types of medicines are in high demand following the advent of mRNA vaccines for Covid and RNA-silencing therapies made by companies like Alnylam Pharmaceuticals.

ReNAgade was able to capitalize on that excitement when it raised a $300 million Series A round led by MPM Capital’s BioImpact Capital and F2 Ventures. But in recent days, the company decided to lay off around 10% of its 100-person team, according to a company statement and former employees’ posts on social media.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： AI models in health care face new federal disclosure requirements

WSS

Americans' trust in science, scientist continues decline: Report

Surgeons perform first xenotransplant using CRISPR'd pig kidney

Patients' immediate access to test results puts radiologists in a bind

Yancopoulos of Regeneron works to expand Dupixent success

'Patient friction coefficient' can gauge a clinical trial's patient burden

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

Wikipedia

leisure time

explore

Supreme Court strikes down use of affirmative action

The woman behind the Dana Farber

How one medical school became remarkably diverse

Texas board proposes rules on abortion law emergency exemption

Continuity nursing helped my family in our darkest PICU moments

Chemotherapy shortages won’t get better under Biden’s latest plan

Malaria cases in Florida and Texas: Here’s what you need to know

Chemotherapy shortages won’t get better under Biden’s latest plan

New air purifier tech could be key to improving indoor air quality

Pharma patents targeted by Biden in move to slash drug prices

Wikipedia

Spinal cord stimulation reduces pain in amputees, study finds

Congenital heart disease patients face new threat of heart failure

6 surprising facts about sugar

STAT letters to the editor on burnt

'Patient friction coefficient' can gauge a clinical trial's patient burden

Radiology is caught between AI's potential and concern for patients

leisure time

focus

explore

explore